BioSyent Inc. (BIOYF)

BioSyent Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	6.46	5.46	6.28	3.8	4.37
Depreciation & Amortization	0.46	0.45	0.46	0.51	0.29
Share-Based Compensation	0.51	0.44	0.33	0.27	0.26
Other Operating Activities	-1.6	-1.4	-2.4	2.32	-0.15
Operating Cash Flow	5.83	4.95	4.67	6.89	4.77
Operating Cash Flow Growth	17.72%	5.86%	-32.19%	44.51%	-24.11%
Capital Expenditures	-2.67	-0.52	-0.09	-0.17	-0.73
Acquisitions	2.5	0	0	0	0
Change in Investments	-5.13	-10.65	-4.89	-3.25	-0.94
Other Investing Activities	5.42	0.38	0.15	6.81	-0.01
Investing Cash Flow	0.11	-10.79	-4.84	3.39	-1.68
Dividends Paid	-1.91	-0.48	0	0	0
Common Stock Issued	0.07	0.04	0.01	0.01	0
Share Repurchases	-3.7	-3.69	-1.85	-3.14	-6.35
Other Financing Activities	-7.63	-7.62	-3.93	-6.52	-12.74
Financing Cash Flow	-5.78	-4.37	-2.08	-3.37	-6.39
Net Cash Flow	-0.39	-10.17	-2.26	6.85	-3.39
Free Cash Flow	3.15	4.43	4.58	6.72	4.04
Free Cash Flow Growth	-28.85%	-3.32%	-31.82%	66.47%	-30.19%
Free Cash Flow Margin	9.98%	15.86%	16.01%	30.09%	18.84%
Free Cash Flow Per Share	0.26	0.35	0.36	0.51	0.29

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.